Beata Duszyńska, PhD

Grzegorz Satała, MSc

 

e-mail: duszyn@if-pan.krakow.pl
phone: +4812 66 23 301

 

 

Publications:

  1. Lacivita, E.; De Giorgio, P.; Patarnello, D.; Niso, M.; Colabufo, N. A.; Berardi, F.; Perrone, R.; Satala, G.; Duszynska, B.; Bojarski, A. J.; Leopoldo, M. Towards metabolically stable 5-HT receptor ligands: a study on 1-arylpiperazine derivatives and related isosters. Exp. Brain Res. 2013, 230, 569-582 (http://www.ncbi.nlm.nih.gov/pubmed/23571499
  2. Kowalski, P.; Mitka, K.; Jaskowska, J.; Duszynska, B.; Bojarski, A. J. New Arylpiperazines with Flexible versus Partly Constrained Linker as Serotonin 5-HT1A /5-HT7 Receptor Ligands. Arch. Pharm. (Weinheim) 2013, 346, 339-348 (http://www.ncbi.nlm.nih.gov/pubmed/23609855)
  3. Chlon-Rzepa, G.; Zmudzki, P.; Satala, G.; Duszynska, B.; Partyka, A.; Wrobel, D.; Jastrzebska-Wiesek, M.; Wesolowska, A.; Bojarski, A. J.; Pawlowski, M.; Zajdel, P. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation. Pharmacol. Rep. 2013, 65, 15-29 (http://www.ncbi.nlm.nih.gov/pubmed/23563020)
  4. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Grychowska, K.; Satala, G.; Duszynska, B.; Lenda, T.; Siwek, A.; Nowak, G.; Partyka, A.; Wrobel, D.; Jastrzebska-Wiesek, M.;  Bojarski, A. J.; Wesolowska, A.; Pawlowski, M. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT(1A)/5-HT(2A)/5-HT(7) and dopamine D(2)/D(3) receptors. Eur. J. Med. Chem. 2013, 60, 42-50 (http://www.ncbi.nlm.nih.gov/pubmed/23279866)
  5. Tokarski, K.; Zelek-Molik, A.; Duszynska, B.; Satała, G.; Bobula, B.; Kusek, M.; Chmielarz, P.; Nalepa, I.; Hess, G. Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus. Pharmacol. Rep. 2012, 64, 2556-65 (http://www.ncbi.nlm.nih.gov/pubmed/22661174)
  6. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Satala, G.; Duszynska, B.; Bojarski, A. J.; Partyka, A.; Jastrzebska-Wiesek, M.; Wrobel, D.; Wesolowska, A.; Pawlowski, M. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation. Bioorg. Med. Chem. 2012, 20, 1545-1556 (http://www.ncbi.nlm.nih.gov/pubmed/22277589)
  7. Jastrzebska-Wiesek, M.; Partyka, A.; Chłoń-Rzepa, G.; Wrobel, D.; Duszyńska, B.; Bojarski, A. J.; Wesołowska, A. Potential anxiolytic, but not antidepressant, activity of new 7-arylpiperazinylbutyl-8-morpholinyl-purine-2,6-dione analogs in mice. Acta Biol. Cracov. Zool. 2011, 53, 29-35
  8. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Paluchowska, M. H.; Satala, G.; Partyka, A.; Jastrzebska-Wiesek, M.; Wrobel, D.; Wesolowska, A.; Duszynska, B.; Bojarski, A. J.; Pawlowski, M. Arene- and quinoline-sulfonamides as novel 5-HT(7) receptor ligands. Bioorg. Med. Chem. 2011, 19, 6750-6759 (http://www.ncbi.nlm.nih.gov/pubmed/22001327).
  9. Kowalski, P.; Jaśkowska, J.; Bojarski, A. J.; Duszyńska, B.; Bucki, A.; Koaczkowski, M. Evaluation of 1-Arylpiperazine Derivative of Hydroxybenzamides as 5-HT1A and 5-HT7 Serotonin Receptor Ligands: An Experimental and Molecular Modeling Approach. J. Heterocyclic Chem. 2011,  48, 192-198
    (http://onlinelibrary.wiley.com/doi/10.1002/jhet.526/abstract).
  10. Saczewski, J.; Paluchowska, A.; Klenc, J.; Raux, E.; Barnes, S.; Sullivan, S.; Duszyńska, B.; Bojarski, A. J.; Strekowski, L. Synthesis of 4-substituted 2-(4-methylpiperazino)pyrimidines and quinazoline analogs as serotonin 5-HT2A receptor ligands. J. Heterocyclic Chem. 2009, 46, 1259-1265 (http://onlinelibrary.wiley.com/doi/10.1002/jhet.236/abstract).
  11. Tokarski, K.; Pitra, P.; Duszynska, B.; Hess, G. Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT(7) receptors in rat hippocampus. J. Physiol Pharmacol. 2009, 60, 83-88 (http://www.ncbi.nlm.nih.gov/pubmed/19617650).
  12. Zajdel, P.; Subra, G. ; Verdie, P.; Gabzdyl, E.; Bojarski, A. J.; Duszynska, B.; Martinez, J.; Pawlowski, M. Sulfonamides with the N-alkyl-N’-dialkylguanidine moiety as 5-HT7 receptor ligands. Bioorg. Med. Chem. Lett. 2009, 19, 4827-4831  (http://www.ncbi.nlm.nih.gov/pubmed/19560916).
  13. Zajdel, P.; Subra, G. ; Verdie, P.; Bojarski, A. J.; Duszynska, B.; Basista, K.; Obniska, J.; Martinez, J.; Pawlowski, M. The influence of an ethylene spacer on the 5-HT(1A) and 5-HT(2A) receptor affinity of arylpiperazine derivatives of amides with N-acylated amino acids and 3-differently substituted pyrrolidine-2,5-diones. Eur. J. Med. Chem. 2009, 44, 800-808 (http://www.ncbi.nlm.nih.gov/pubmed/18603331).
  14. Iskra-Jopa, J.; Golembiowska, K.; Dziubina, A.; Cybulski, M.; Duszynska, B.; Chilmonczyk, Z. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex. J. Pharm. Pharmacol. 2005, 57, 205-211 (http://www.ncbi.nlm.nih.gov/pubmed/15720784).
  15. Kolaczkowski, M.; Zajdel, P.; Fhid, O.; Duszynska, B.; Tatarczynska, E.; Pawlowski, M. Synthesis and 5-HT(1A)/5-HT(2A) activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f] theophyllines. Pharmacol. Rep. 2005, 57, 229-235 (http://www.ncbi.nlm.nih.gov/pubmed/15886422).
  16. Byrtus, H.; Pawlowski, M.; Czopek, A.; Bojarski, A. J.; Duszynska, B.; Nowak, G.; Klodzinska, A.; Tatarczynska, E.; Wesolowska, A.; Chojnacka-Wojcik, E. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins. Eur. J. Med. Chem. 2005, 40, 820-829 (http://www.ncbi.nlm.nih.gov/pubmed/16122584).
  17. Zajdel, P.; Subra, G.; Bojarski, A. J.; Duszynska, B.; Pawlowski, M.; Martinez, J. Parallel solid-phase synthesis and characterization of new sulfonamide and carboxamide proline derivatives as potential CNS agents. Bioorg. Med. Chem. 2005, 13, 3029-3035 (http://www.ncbi.nlm.nih.gov/pubmed/15781412).
  18. Zajdel, P.; Subra, G.; Bojarski, A. J.; Duszynska, B.; Pawlowski, M.; Martinez, J. Parallel solid-phase synthesis and characterization of new sulfonamide and carboxamide proline derivatives as potential CNS agents. Bioorg. Med. Chem. 2005, 13, 3029-3035 (http://www.ncbi.nlm.nih.gov/pubmed/15781412).
  19. Bojarski, A. J.; Paluchowska, M. H.; Duszyńska, B.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), α1-adrenergic and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics. Bioorg. Med. Chem. 2005, 13, 2293-3303 (http://www.ncbi.nlm.nih.gov/pubmed/15727878).
  20. Paluchowska, M. H.; Bugno, R.; Bojarski, A. J.; Charakchieva-Minol, S.; Duszyńska, B.; Tatarczyńska, E.; Kłodzinska, A.; Stachowicz, K.; Chojnacka-Wójcik, E. Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity. Bioorg. Med. Chem. 2005, 13, 1195-1200 (http://www.ncbi.nlm.nih.gov/pubmed/15670928).
  21.  Kowalska, T.; Kowalski, P.; Bojarski, A. J.; Duszyńska, B. Studies on the syntheses of 1-substituted benzimidazole derivatives. Acta Pol. Pharm. -Drug Res. 2004, 61, 361-366 (http://www.ncbi.nlm.nih.gov/pubmed/15747692).
  22. Bojarski, A. J.; Duszyńska, B.; Kołaczkowski, M.; Kowalski, P.; Kowalska, T. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands. Bioorg. Med. Chem. Lett. 2004, 14, 5863-5866 (http://www.ncbi.nlm.nih.gov/pubmed/15501057).
  23. Zajdel, P.; Subra, G.; Bojarski, A. J.; Duszyńska, B.; Pawłowski, M.; Martinez, J. A new class of arylpiperazine derivatives: the library synthesis on SynPhase lanterns and biological evaluation on serotonin 5-HT1A and 5-HT2A receptors. J. Comb. Chem. 2004, 6, 761-767 (http://www.ncbi.nlm.nih.gov/pubmed/15360211).
  24. Jurczyk, S.; Kołaczkowski, M.; Maryniak, E.; Zajdel, P.; Pawłowski, M.; Tatarczyńska, E.; Kłodzinska, A.; Chojnacka-Wojcik, E.; Bojarski, A. J.; Charakchieva-Minol, S.; Duszyńska, B.; Nowak, G.; Maciąg, D. New arylpiperazine 5-HT1A receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. J. Med. Chem. 2004, 47, 2659-2666 (http://www.ncbi.nlm.nih.gov/pubmed/15115407).
  25. Bojarski, A. J.; Mokrosz, M. J.; Duszyńska, B.; Kozioł, A.; Bugno, R. New Imide 5-HT1A Receptor Ligands Modification of Terminal Fragment Geometry. Molecules 2004, 3, 170-177 (http://www.ncbi.nlm.nih.gov/pubmed/18007421)
  26. Bojarski, A. J.; Kowalski, P.; Suder, P.; Kowalska, T.; Sikorska-Jarosz, J.; Silberring, J.; Duszynska, B.; Nowak, M. ESI-mass spectrometric studies of the non-covalent complexes of triethylamine salts. Annals of the Polish Chemical Society 2003, 2, 13-17.
  27. Boksa, J.; Charakchieva-Minol, S.; Duszynska, B.; Bugno, R.; Klodzinska, A.; Tatarczynska, E.; Chojnacka-Wojcik, E.; Bojarski, A. J. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-γ-carbolines with 1-(2-methoxyphenyl)piperazine moiety. Pol. J. Pharmacol. 2003, 55, 1013-1019 (http://www.ncbi.nlm.nih.gov/pubmed/14730096).
  28. Obniska, J.; Pawłowski, M.; Kołaczkowski, M.; Czopek, A.; Duszyńska, B.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. Synthesis and 5-HT1A /5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-β-tetralonepyrrolidine-2,5-dione. Pol. J. Pharmacol. 2003, 55, 553-557 (http://www.ncbi.nlm.nih.gov/pubmed/14581713)
  29. Paluchowska, M. H.; Mokrosz, M. J. ; Duszyńska, B.; Kozioł, A.; Wesołowska, A.; Chojnacka-Wójcik, E. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity. Pol. J. Pharmacol. 2003, 55, 543-552 (http://www.ncbi.nlm.nih.gov/pubmed/14581712).
  30. Kowalski, P.; Suder, P.; Kowalska, T.; Silberring, J.; Duszyńska, B.; Bojarski, A. J. Electrospray mass spectrometric studies of noncovalent complexes of buspirone hydrochloride and other serotonin 5-HT1A receptor ligands containing arylpiperazine moieties. Rapid Commun. Mass Spectrom. 2003, 17, 2139-2146 (http://www.ncbi.nlm.nih.gov/pubmed/12955745).
  31. Bojarski, A. J.; Kowalski, P.; Kowalska, T.; Duszyńska, B.; Charakchieva-Minol, S.; Tatarczyńska, E.; Kłodzińska, A.; Chojnacka-Wojcik, E. Synthesis and pharmacological evaluation of new arylpiperazines. 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one – a dual serotonin 5-HT1A/5-HT2A receptor ligand with an anxiolytic-like activity. Bioorg. Med. Chem. 2002, 10, 3817-3827 (http://www.ncbi.nlm.nih.gov/pubmed/12413835).
  32. Kowalski, P.; Jaśkowska, J.; Bojarski, A. J.; Duszyńska, B. The synthesis of Cyclic and Acyclic Long-chain Arylpiperazine Derivatives of Salicyc Amide as Serotonin Receptor Ligands. J. Heterocyclic Chem. 2008, 45, 209-214.
  33. Paluchowska, M. H.; Bugno, R.; Duszynska, B.; Tatarczynska, E.; Nikiforuk, A.; Lenda, T.; Chojnacka-Wojcik, E. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines. Bioorg. Med. Chem. 2007, 15, 7116-7125 (http://www.ncbi.nlm.nih.gov/pubmed/17825569).
  34. Kowalski, P.; Kowalska, T.; Bojarski, A. J.; Duszyńska, B. Synthesis and Biological Properties of 1,8-Naphthalimidebutylamines. Serotonin 5-HT1A and 5-HT7 Binding Data and PASS-Assisted Search. J. Heterocyclic Chem. 2007, 44, 889-893 (http://onlinelibrary.wiley.com/doi/10.1002/jhet.5570440423/abstract).
  35. Chlon-Rzepa, G.; Zmudzki, P.; Zajdel, P.; Bojarski, A. J.; Duszynska, B.; Nikiforuk, A.; Tatarczynska, E.; Pawlowski, M. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands. Bioorg. Med. Chem. 2007, 15, 5239-5250 (http://www.ncbi.nlm.nih.gov/pubmed/17517514).
  36. Zajdel, P.; Subra, G.; Bojarski, A. J.; Duszynska, B.; Tatarczynska, E.; Nikiforuk, A.; Chojnacka-Wojcik, E.; Pawlowski, M. ; Martinez, J. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Bioorg. Med. Chem. 2007, 15, 2907-2919 (http://www.ncbi.nlm.nih.gov/pubmed/17321139).
  37. Obniska, J.; Kolaczkowski, M.; Bojarski, A. J.; Duszynska, B. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Eur. J. Med. Chem. 2006, 41, 874-881 (http://www.ncbi.nlm.nih.gov/pubmed/16600439).
  38. Zajdel, P.; Subra, G.; Bojarski, A. J.; Duszynska, B.; Pawlowski, M.; Martinez, J. Arylpiperazines with N-acylated amino acids as 5-HT(1A) receptor ligands. Bioorg. Med. Chem. Lett. 2006, 16, 3406-3410 (http://www.ncbi.nlm.nih.gov/pubmed/16677812).
  39. Obniska, J.; Tatarczynska, E.; Nikiforuk, A.; Charakchieva-Minol, S.; Duszynska, B. Synthesis and 5-HT(1A)/5-HT(2A) receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione. Pharmacol. Rep. 2006, 58, 107-114 (http://www.ncbi.nlm.nih.gov/pubmed/16531637).
  40. Bojarski, A. J.; Paluchowska, M. H.; Duszynska, B.; Bugno, R.; Klodzinska, A.; Tatarczynska, E.; Chojnacka-Wojcik, E. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT(1A) receptor agents with anxiolytic- like activity. Bioorg. Med. Chem. 2006, 14, 1391-1402 (http://www.ncbi.nlm.nih.gov/pubmed/16266808).
  41. Byrtus, H.; Pawłowski, M.; Duszyńska, B.; Wesołowska, A. ; Chojnacka-Wójcik, E.; Bojarski, A. J. Arylpiperazine derivatives of 3-propyl-β-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands. Pol. J. Pharmacol. 2001, 53, 395-401 (http://www.ncbi.nlm.nih.gov/pubmed/11990087).
  42. Chłoń, G.; Pawłowski, M.; Duszyńska, B.; Szaro, A.; Tatarczyńska, E.; Kłodzińska, A.; Chojnacka-Wójcik, E. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione. Pol. J. Pharmacol. 2001, 53, 359-368 (http://www.ncbi.nlm.nih.gov/pubmed/11990082).
  43. Duszyńska, B.; Misztal, S. Ligandy receptorów serotoninowych w terapii migreny. Wiad. Chem. 2001, 55, 45-66 (http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.baztech-article-BUS1-0010-0003)
  44. Mokrosz, M. J.; Duszyńska, B.; Wesołowska, A.; Borycz, J.; Chojnacka-Wójcik, E.; Karolak-Wojciechowska, J. 1-Aryl-1,4-dihydro-3(2H)-isoquinolinones: two modes of interaction with 5-HT1A receptors. Med. Chem. Res. 2000, 10, 58-68.
  45. Paluchowska, M. H.; Duszyńska, B.; Kłodzińska, A.; Tatarczyńska, E. Influence of the aliphatic spacer length on the 5-HT1A receptor activity of new arylpiperazines with an indazole system. Pol. J. Pharmacol. 2000, 52, 209-216 (http://www.ncbi.nlm.nih.gov/pubmed/11055578).
  46. Kowalski, P.; Mokrosz, M. J.; Majka, Z.; Kowalska, T.; Duszyńska, B. Biologically active 1-arylpiperazine. Synthesis of N-[3-(4-aryl-1-piperazinyl)propyl derivatives of benzoxazinone and benzoxazolinone. J. Heterocyclic Chem. 2000, 37, 187-189 (http://onlinelibrary.wiley.com/doi/10.1002/jhet.5570370132/abstract).
  47. Mokrosz, M. J.; Kowalski, P.; Kowalska, T.; Majka, Z.; Duszyńska, B.; Bojarski, A. J.; Fruziński, A.; Karolak-Wojciechowska, J.; Wesołowska, A.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. Structure-activity relationship studies of CNS agents. Part 38. Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities. Arch. Pharm. (Weinheim) 1999, 332, 373-379 (http://www.ncbi.nlm.nih.gov/pubmed/10605377).
  48. Pawłowski, M.; Katlabi, J.; Drabczyńska, A.; Duszyńska, B.; Charakchieva-Minol, S.; Dereń-Wesołek, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E.; Mokrosz, M. J. ; Bojarski, A. J. New 9- or 10-arylpiperazinoalkyl substituted pyrimido- or diazepino[2,1-f]purines with partial or full 5-HT1A agonistic activity. Eur. J. Med. Chem. 1999, 34, 167-175 (http://www.sciencedirect.com/science/article/pii/S0223523499800506).
  49. Mokrosz, M. J.; Bojarski, A. J.; Duszyńska, B.; Tatarczyńska, E.; Kłodzińska, A.; Dereń-Wesołek, A.; Charakchieva-Minol, S.; Chojnacka-Wójcik, E. 1,2,3,4-Tetrahydroisoquinoline derivatives: a new class of 5-HT1A receptor ligands. Bioorg. Med. Chem. 1999, 7, 287-295 (http://www.ncbi.nlm.nih.gov/pubmed/10218820).
  50. Mokrosz, M. J.; Kowalski, P.; Kowalska, T.; Majka, Z.; Duszyńska, B.; Charakchieva-Minol, S.; Szaro, A.; Tatarczyńska, E.; Kłodzińska, A.; Chojnacka-Wójcik, E. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity. Pol. J. Pharmacol. 1998, 50, 333-340 (http://www.ncbi.nlm.nih.gov/pubmed/10091718).
  51. Mokrosz, M. J.; Duszyńska, B.; Misztal, S.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E.; Dziedzicka-Wasylewska, M. A search for new 5-HT1A/5-HT2A receptor ligands. In vitro and in vivo studies of 1-[ω-(4-aryl-1-piperazinyl)alkyl]indolin-2(1H)-ones. Arch. Pharm. (Weinheim) 1998, 331, 325-330 (http://www.ncbi.nlm.nih.gov/pubmed/9844580).
  52. Mokrosz, M. J.; Duszyńska, B.; Kłodzińska, A.; Dereń-Wesołek, A.; Chojnacka-Wójcik, E.; Baranowski, T. C.; Abdou, I. M.; Pedmore, N. P.; Strekowski, L. 4-(3-Furyl)-2-(4-methylpiperazino)pyrimidines: potent 5-HT2A receptor antagonists. Bioorg. Med. Chem. Lett. 1997, 7, 1635-1638 (http://www.sciencedirect.com/science/article/pii/S0960894X97002916).
  53. Mokrosz, M. J.; Mokrosz, J. L.; Duszyńska, B.; Dereń-Wesołek, A.; Kłodzińska, A.; Kowalski, P.; Charakchieva-Minol, S.; Tatarczyńska, E.; Kowalska, T.; Majka, Z.; Chojnacka-Wójcik, E.; Misztal, S. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents. Pharmazie 1997, 52, 423-428 (http://www.ncbi.nlm.nih.gov/pubmed/9260266).
  54. Mokrosz, J. L.; Duszyńska, B.; Charakchieva-Minol, S.; Bojarski, A. J.; Mokrosz, M. J.; Wydra, R. L.; Janda, L.; Strekowski, L. Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel α1, 5-HT 1A and 5-HT2A receptor ligands. Eur. J. Med. Chem. 1996, 31, 973-980 (http://scholar.qsensei.com/content/3wrsx).
  55. Byrtus, H.; Pawłowski, M.; Charakchieva-Minol, S.; Duszyńska, B.; Mokrosz, M. J.; Mokrosz, J. L.; Zejc, 3-(ω -Aminoalkyl)-5,5-dialkyl(or spirocycloalkyl-1,5-)hydantions as New 5-HT1A and 5-HT2A Receptor Ligands. Arch. Pharm. (Weinheim) 1996, 6, 283-290 (http://www.ncbi.nlm.nih.gov/pubmed/8767112).
  56. Mokrosz, J. L.; Dereń-Wesołek, A.; Tatarczyńska, E.; Duszyńska, B.; Bojarski, A. J.; Mokrosz, M. J.; Chojnacka-Wójcik, E. 8-{4-[2-(1,2,3,4-Tetrahydroisoquinolinyl)]-butyl}-9-azaspiro[4.5]decane-7,9-dione: A New 5-HT1A Receptor Ligand with the Same Activity Profile as Buspirone. J. Med. Chem. 1996, 39, 1125-1129 (http://www.ncbi.nlm.nih.gov/pubmed/8676348).
  57. Mokrosz, M. J.; Strekowski, L.; Kozak, W. X.; Duszyńska, B.; Bojarski, A. J.; Kłodzińska, A.; Czarny, A.; Cegła, M. T.; Dereń-Wesołek, A.; Chojnacka-Wójcik, E.; Dove, S.; Mokrosz, J. L. Structure-Activity Relationship Studies of CNS Agents. Part 25. 4,6-Di(heteroaryl)-2-(N-methylpiperazino)pyrimidines as New, Potent 5-HT2A Receptor Ligands: A Verification of the Topographic Model. Arch. Pharm. (Weinheim) 1995, 328, 659-666 (http://www.ncbi.nlm.nih.gov/pubmed/7487423).
  58. Mokrosz, J. L.; Bojarski, A. J.; Charakchieva-Minol, S.; Duszyńska, B.; Mokrosz, M. J. Structure-Activity Relationship Studies of CNS Agents. Part 23. N-(3-Phenylpropyl)- and N-[(E)-Cinnamyl]-1,2,3,4-tetrahydroisoquinoline Mimic 1-Phenylpiperazine at 5-HT1A Receptors. Arch. Pharm. (Weinheim) 1995, 328, 604-608 (http://www.ncbi.nlm.nih.gov/pubmed/7492265).
  59. Mokrosz, J. L.; Duszyńska, B.; Paluchowska, M. H.; Charakchieva-Minol, S.; Mokrosz, M. J. Structure-Activity Relationship Studies of CNS Agents. Part 22. A Search for New Trazodone-Like Antidepressants: Synthesis and Preliminary Receptor Binding Studies. Arch. Pharm. (Weinheim) 1995, 328, 623-625 (http://www.ncbi.nlm.nih.gov/pubmed/7492269).
  60. Bojarski, A. J., Duszyńska, B. Modelowanie cząsteczkowe – kilka uwag o sprzęcie i oprogramowaniu. In Modelowanie cząsteczkowe w chemii leków, skrypt z III Krakowskiej Konferencji Chemii Leków, Mogilany 8-9.06.95; Mokrosz, J. L. Kraków, 1995; p. 137-140.
  61. Mokrosz, M. J.; Duszyńska, B.; Bojarski, A. J.; Mokrosz, J. L. Structure-Activity Relationship Studies of CNS Agents – XVII. Spiro[piperidine-4’,1-(1,2,3,4-tetrahydro-β-carboline)] as a Probe Defining the Extended Topographic Model of 5-HT1A Receptors. Bioorg. Med. Chem. 1995, 3, 533-538 (http://www.ncbi.nlm.nih.gov/pubmed/7648202).
  62. Mokrosz, J. L.; Kłodzińska, A.; Boksa, J.; Bojarski, A. J.; Duszyńska, B.; Chojnacka-Wójcik, E. Structure-Activity Relationship Studies of CNS Agents, XXI: Two Derivatives of 1-(o-Methoxyphenyl)piperazine with an Opposite Function at 5-HT1A Receptors. Arch. Pharm. (Weinheim) 1995, 328, 381-383 (http://www.ncbi.nlm.nih.gov/pubmed/7611833).
  63. Boksa, J.; Duszyńska, B.; Mokrosz, J. L. Structure-Activity Relationship Studies of CNS Agents. Part 20: 9-{ω-[1-( m-Chlorophenyl)-4-piperazinyl]alkyl}-1,2,3,4-tetrahydro-β-carbolines: New 5-HT1A and 5-HT2A Receptor Ligands. Pharmazie 1995, 50, 220-221 (http://www.ncbi.nlm.nih.gov/pubmed/7732057).
  64. Mokrosz, J. L.; Mokrosz, M. J.; Charakchieva-Minol, S.; Paluchowska, M. H.; Bojarski, A. J.; Duszyńska, B. Structure-Activity Relationship Studies of CNS Agents, XIX: Quantitative Analysis of the Alkyl Chain Effects on the 5-HT1A and 5-HT2 Receptor Affinities of 4-Alkyl-1-arylpiperazines and their Analogs. Arch. Pharm. (Weinheim) 1995, 328, 143-148 (http://www.ncbi.nlm.nih.gov/pubmed/7726740).